Article thumbnail

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

By Karen S. McCoy, Alexandra L. Quittner, Christopher M. Oermann, Ronald L. Gibson, George Z. Retsch-Bogart and A. Bruce Montgomery

Abstract

Rationale: The effectiveness and safety of aztreonam lysine for inhalation (AZLI) in patients with cystic fibrosis (CF) on maintenance treatment for Pseudomonas aeruginosa (PA) airway infection was evaluated in this randomized, double-blind, placebo-controlled study

Topics: B. Cystic Fibrosis
Publisher: American Thoracic Society
OAI identifier: oai:pubmedcentral.nih.gov:2577727
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.